These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 3493440

  • 1. Anti-idiotypes in B-cell tumor therapy.
    Miller RA, Lowder J, Meeker TC, Brown S, Levy R.
    NCI Monogr; 1987; (3):131-4. PubMed ID: 3493440
    [Abstract] [Full Text] [Related]

  • 2. A clinical trial of anti-idiotype therapy for B cell malignancy.
    Meeker TC, Lowder J, Maloney DG, Miller RA, Thielemans K, Warnke R, Levy R.
    Blood; 1985 Jun; 65(6):1349-63. PubMed ID: 3888313
    [Abstract] [Full Text] [Related]

  • 3. The generation of monoclonal anti-idiotype antibodies to human B cell-derived leukemias and lymphomas.
    Giardina SL, Schroff RW, Kipps TJ, Woodhouse CS, Abrams PG, Rager HC, Morgan AC, Foon KA.
    J Immunol; 1985 Jul; 135(1):653-8. PubMed ID: 3873497
    [Abstract] [Full Text] [Related]

  • 4. Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variants.
    Kaminski MS, Kitamura K, Maloney DG, Campbell MJ, Levy R.
    J Immunol; 1986 Feb 01; 136(3):1123-30. PubMed ID: 3484499
    [Abstract] [Full Text] [Related]

  • 5. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May 01; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody].
    Kon S.
    Gan To Kagaku Ryoho; 1988 May 01; 15(5):1685-92. PubMed ID: 3259417
    [Abstract] [Full Text] [Related]

  • 7. Strategies for production of monoclonal anti-idiotype antibodies against human B cell lymphomas.
    Thielemans K, Maloney DG, Meeker T, Fujimoto J, Doss C, Warnke RA, Bindl J, Gralow J, Miller RA, Levy R.
    J Immunol; 1984 Jul 01; 133(1):495-501. PubMed ID: 6609992
    [Abstract] [Full Text] [Related]

  • 8. Therapy of lymphoma directed at idiotypes.
    Levy R, Miller RA.
    J Natl Cancer Inst Monogr; 1990 Jul 01; (10):61-8. PubMed ID: 1693283
    [Abstract] [Full Text] [Related]

  • 9. The use of a monoclonal anti-idiotype antibody to study the biology of a human B cell lymphoma.
    Hatzubai A, Maloney DG, Levy R.
    J Immunol; 1981 Jun 01; 126(6):2397-402. PubMed ID: 6785351
    [Abstract] [Full Text] [Related]

  • 10. Differences in "host infiltrates" among lymphoma patients treated with anti-idiotype antibodies: correlation with treatment response.
    Garcia CF, Lowder J, Meeker TC, Bindl J, Levy R, Warnke RA.
    J Immunol; 1985 Dec 01; 135(6):4252-60. PubMed ID: 2933460
    [Abstract] [Full Text] [Related]

  • 11. Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma.
    Timmerman JM, Singh G, Hermanson G, Hobart P, Czerwinski DK, Taidi B, Rajapaksa R, Caspar CB, Van Beckhoven A, Levy R.
    Cancer Res; 2002 Oct 15; 62(20):5845-52. PubMed ID: 12384547
    [Abstract] [Full Text] [Related]

  • 12. Molecules recognized by anti-idiotypic monoclonal antibodies to the B cell lymphoma, BCL1.
    Tamura GS, McGrath MS, Weissman IL.
    J Mol Cell Immunol; 1987 Oct 15; 3(4):243-53. PubMed ID: 3509925
    [Abstract] [Full Text] [Related]

  • 13. Synergistic antitumor effect of interferon and anti-idiotype monoclonal antibody in murine lymphoma.
    Basham TY, Kaminski MS, Kitamura K, Levy R, Merigan TC.
    J Immunol; 1986 Nov 01; 137(9):3019-24. PubMed ID: 3760580
    [Abstract] [Full Text] [Related]

  • 14. Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy.
    Schroff RW, Foon KA, Beatty SM, Oldham RK, Morgan AC.
    Cancer Res; 1985 Feb 01; 45(2):879-85. PubMed ID: 3871353
    [Abstract] [Full Text] [Related]

  • 15. Monoclonal antibody therapy of lymphoid malignancy.
    Lowder JN, Meeker TC, Levy R.
    Cancer Surv; 1985 Feb 01; 4(2):359-75. PubMed ID: 3842318
    [Abstract] [Full Text] [Related]

  • 16. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
    Wagner U, Köhler S, Prietl G, Giffels P, Schmidt-Nicolai S, Schlebusch H, Grünn U, Bender H, Biersack HJ, De Potter C, Krebs D, Wallwiener D.
    Zentralbl Gynakol; 1999 Feb 01; 121(4):190-5. PubMed ID: 10355096
    [Abstract] [Full Text] [Related]

  • 17. Phase I trial of a novel intradermal idiotype vaccine in patients with advanced B-cell lymphoma: specific immune responses despite profound immunosuppression.
    Bertinetti C, Zirlik K, Heining-Mikesch K, Ihorst G, Dierbach H, Waller CF, Veelken H.
    Cancer Res; 2006 Apr 15; 66(8):4496-502. PubMed ID: 16618777
    [Abstract] [Full Text] [Related]

  • 18. Therapeutic lymphoma vaccines: importance of T-cell immunity.
    Neelapu SS, Lee ST, Qin H, Cha SC, Woo AF, Kwak LW.
    Expert Rev Vaccines; 2006 Jun 15; 5(3):381-94. PubMed ID: 16827622
    [Abstract] [Full Text] [Related]

  • 19. Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody.
    Foon KA.
    N Engl J Med; 1982 Sep 09; 307(11):686-7. PubMed ID: 6981064
    [No Abstract] [Full Text] [Related]

  • 20. Human immune response to multiple injections of murine monoclonal IgG.
    Shawler DL, Bartholomew RM, Smith LM, Dillman RO.
    J Immunol; 1985 Aug 09; 135(2):1530-5. PubMed ID: 3874237
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.